Ad is loading...
APWEX vs FSENX
APWEX vs FSENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
APWEX vs. FSENX commentary
Jan 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APWEX is a StrongBuy and FSENX is a Buy.
FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 1.92B vs. APWEX (110M). APWEX pays higher dividends than FSENX: APWEX (1.85) vs FSENX (1.72). APWEX was incepted earlier than FSENX: APWEX (11 years) vs FSENX (44 years). APWEX is a more actively managed with annual turnover of: 166.00 vs. FSENX (43.00). FSENX has a lower initial minimum investment than APWEX: FSENX (0) vs APWEX (100). APWEX annual gain was more profitable for investors over the last year : 28.74 vs. FSENX (18.69). APWEX return over 5 years is better than : 132.70 vs. FSENX (98.64).
| APWEX | FSENX | APWEX / FSENX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 11 years | 44 years | - |
| Gain YTD | 8.909 | 8.628 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 110M | 1.92B | 6% |
| Annual Yield % from dividends | 1.85 | 1.72 | 107% |
| Returns for 1 year | 28.74 | 18.69 | 154% |
| Returns for 3 years | 50.97 | 58.97 | 86% |
| Returns for 5 years | 132.70 | 98.64 | 135% |
| Returns for 10 years | 95.70 | 62.31 | 154% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FERIX | 48.89 | 0.64 | +1.33% |
| Fidelity Advisor Emerging Asia I | |||
| FGIRX | 42.36 | 0.35 | +0.83% |
| Fidelity Advisor Growth & Income A | |||
| JIEZX | 18.69 | 0.09 | +0.48% |
| JPMorgan International Equity R2 | |||
| MSBQX | 11.74 | 0.03 | +0.26% |
| Morgan Stanley American Resilience R6 | |||
| RCGHX | 16.49 | N/A | N/A |
| Virtus KAR Health Sciences C | |||